Vivos (RDGL) EPS (Basic) Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vivos | - | - | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -49.13% |
| Sep 30, 2025 | -12.05% |
| Jun 30, 2025 | 54.42% |
| Mar 31, 2025 | 53.08% |
| Dec 31, 2024 | 68.76% |
| Sep 30, 2024 | 12.67% |
| Jun 30, 2024 | -77.02% |
| Mar 31, 2024 | -0.16% |
| Dec 31, 2023 | -14.95% |
| Sep 30, 2023 | 68.27% |
| Jun 30, 2023 | 66.01% |
| Mar 31, 2023 | 41.50% |
| Dec 31, 2022 | 47.43% |
| Sep 30, 2022 | 54.21% |
| Jun 30, 2022 | 41.24% |
| Mar 31, 2022 | 28.63% |
| Dec 31, 2021 | -15.00% |
| Sep 30, 2021 | -72.62% |
| Jun 30, 2021 | -36.63% |
| Mar 31, 2021 | -54.64% |
| Dec 31, 2020 | -15.18% |
| Sep 30, 2020 | 65.50% |
| Jun 30, 2020 | -87.65% |
| Mar 31, 2020 | -147.55% |
| Dec 31, 2019 | -146.40% |
| Sep 30, 2019 | -0.50% |
| Jun 30, 2019 | 34.78% |
| Mar 31, 2019 | 32.29% |
| Dec 31, 2018 | 167.51% |
| Sep 30, 2018 | -123.69% |
| Jun 30, 2018 | -139.90% |
| Mar 31, 2018 | 0.00% |
| Dec 31, 2017 | 0.00% |
| Sep 30, 2017 | -5.92% |
| Jun 30, 2017 | -1.74% |
| Mar 31, 2017 | -1.92% |
| Dec 31, 2016 | 47.58% |
| Sep 30, 2016 | 0.00% |
| Jun 30, 2016 | 26.81% |
| Mar 31, 2016 | 21.93% |
| Dec 31, 2015 | 47.58% |
| Sep 30, 2015 | -45.41% |
| Jun 30, 2015 | 18.53% |